Antidepressant-Like Effects of n-Butylidenephthalide Using In Vivo and In Silico Approaches

<b>Background:</b> The plant-derived compound n-butylidenephthalide (BP) is an isobenzofuranone that has shown neuropharmacological effects on preclinical models of Parkinson's, Alzheimer's, and amyotrophic lateral sclerosis. <b>Methods</b>: This study evaluated the anti-inflammatory, antinociceptive, anxiolytic-like, hypnotic, anticonvulsant, and antidepressant-like effects of BP (50-200 mg/kg p.o.) using Balb/c mice in acute assays. This study also evaluated the antidepressant-like effects of BP in a mouse model of reserpine-induced depression-like behavior for 20 days. Inhibitors involved in the molecular process of depression and in silico studies were used to evaluate a possible mechanism of action for the antidepressant-like effects of BP. <b>Results</b>: BP induced low anti-inflammatory effects, showed low anticonvulsant effects, and lacked hypnotic effects or motor impairment in acute assays. The antidepressant-like effects of BP (100-200 mg/kg p.o.) were comparable to amitriptyline (25 mg/kg p.o.) in acute assays. The participation of serotonergic and adrenergic systems is involved in the acute antidepressant-like effects of BP. In the reserpine-induced depression model, BP (100 mg/kg p.o.) showed antidepressant-like effects in one of the two antidepressant tests, but with a lower effect than amitriptyline (20 mg/kg p.o.). <b>Conclusions:</b> BP (100 and 200 mg/kg) showed antidepressant-like effects in acute assays and, to a lesser extent, in a reserpine-induced chronic model of depression-like behavior.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-01-30
DOI
https://doi.org/10.3390/ph19020242
Primary Topic
Neurological Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antidepressant-Like Effects of n-Butylidenephthalide Using In Vivo and In Silico Approaches

Ángel Josabad Alonso‐Castro, Diana Casique Aguirre, Athzirys Alejandra Melecio-Hernández, Gabriela Josefina López-González et al.
Pharmaceuticals
Neurological Disease Mechanisms and Treatments
article

Antidepressant-Like Effects of n-Butylidenephthalide Using In Vivo and In Silico Approaches

Ángel Josabad Alonso‐Castro, Diana Casique Aguirre, Athzirys Alejandra Melecio-Hernández, Gabriela Josefina López-González, Juan Ramón Zapata-Morales, Ramsés Maximiliano Ramírez-Martínez, María Leonor González-Rivera, María del Carmen Juárez-Vázquez, Andrea Ayala-Torres, Yurisleidys Quesada-Mendiola
article en

Abstract

<b>Background:</b> The plant-derived compound n-butylidenephthalide (BP) is an isobenzofuranone that has shown neuropharmacological effects on preclinical models of Parkinson's, Alzheimer's, and amyotrophic lateral sclerosis. <b>Methods</b>: This study evaluated the anti-inflammatory, antinociceptive, anxiolytic-like, hypnotic, anticonvulsant, and antidepressant-like effects of BP (50-200 mg/kg p.o.) using Balb/c mice in acute assays. This study also evaluated the antidepressant-like effects of BP in a mouse model of reserpine-induced depression-like behavior for 20 days. Inhibitors involved in the molecular process of depression and in silico studies were used to evaluate a possible mechanism of action for the antidepressant-like effects of BP. <b>Results</b>: BP induced low anti-inflammatory effects, showed low anticonvulsant effects, and lacked hypnotic effects or motor impairment in acute assays. The antidepressant-like effects of BP (100-200 mg/kg p.o.) were comparable to amitriptyline (25 mg/kg p.o.) in acute assays. The participation of serotonergic and adrenergic systems is involved in the acute antidepressant-like effects of BP. In the reserpine-induced depression model, BP (100 mg/kg p.o.) showed antidepressant-like effects in one of the two antidepressant tests, but with a lower effect than amitriptyline (20 mg/kg p.o.). <b>Conclusions:</b> BP (100 and 200 mg/kg) showed antidepressant-like effects in acute assays and, to a lesser extent, in a reserpine-induced chronic model of depression-like behavior.

PharmaceuticalsVol. 19(2)
Universidad de Guanajuato (MX), Secretaria de Salud (MX)
Good health and well-being
Openalex Percentile: Top 76%
Neurological Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.